P
Petal Surgical
Stealth health-tech platform for incisionless, non-invasive surgery
About Petal Surgical
Petal Surgical, Inc. is a health technology company operating in stealth mode since its founding in 2021. The company's stated mission is to establish non-invasive surgery as the standard for interventional care. Based in Foster City, California, Petal Surgical is developing a platform intended to make surgical procedures accessible and incisionless. It is backed by investors including K50 Ventures, ShangBay Capital, TSV Capital, Zenture Capital Partners, and the University of Washington.
The company's research and development efforts are focused on medical robotics and advanced visualization. A patent application filed by the company describes a system for enhanced reality medical guidance. This technology uses a combination of external imaging, cameras, and fiducial markers to generate and display real-time 2D or 3D images of a surgical tool inside a patient's body, aiming to guide medical procedures. The listed inventors on this patent are Prashant Chopra and Salil S. Joshi.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Redwood City, United States
- Employees
- 24
- Open positions
- 1
- Dealroom signal
- 89.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Spinout, Surgical Equipment, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Jun 2026 | $0 | — | A&E Investments · Time Ventures · Blue Pool Capital · K50 Ventures | ↗ |
| SERIES AOther financing | Oct 2025 | $10M | $40M | Draper Associates · TSVC · ShangBay Capital · Frederic Moll | ↗ |
Growth signals
Latest recorded traffic for Petal Surgical is 580 monthly website visits, down 35.6% over the last three months. Petal Surgical's team grew 242.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A10 investors entered at this stage
TSVC
K50 Ventures
Draper Associates
ShangBay Capital
Frederic Moll
Eliot Horowitz
Blue Pool Capital
A&E Investments
Time Ventures
Salience Capital
Other known investors2 additional known investors
University of Washington- LWLisheng Wang
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Petal Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Petal Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






